Bookmark
Forward
Explore Literature Results
Explore Clinical Trials Results
QuickView for CDK6 (gene)
Most Relevant Literature
- miR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition by Targeting CDK6 in Nasal Polyps.
- CDK6 increases glycolysis and suppresses autophagy by mTORC1-HK2 pathway activation in cervical canc…
- Reply to Fusco et al. Is Medication-Related Osteonecrosis of the Jaws (MRONJ) Associated to Cyclin-D…
- Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and D…
- Monocyte subpopulation profiling indicates CDK6-derived cell differentiation and identifies subpopul…
Most Relevant Clinical Trials
- Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Enc…
- Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Can…
- Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplast…
- Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic Leukemia
- Study of Palbociclib in MLL-rearranged Acute Leukemias
